Structural and Functional Characterization of MERS Coronavirus Papain-like Protease

Overview

Journal J Biomed Sci

Publisher Biomed Central

Specialty Biology

Date 2014 Jun 6

PMID 24898546

Citations 30

Authors

Min-Han Lin

Shang-Ju Chuang

Chiao-Che Chen

Shu-Chun Cheng

Kai-Wen Cheng

Chao-Hsiung Lin

Chiao-Yin Sun

Chi-Yuan Chou

Affiliations

Soon will be listed here.

Abstract

Backgrounds: A new highly pathogenic human coronavirus (CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), has emerged in Jeddah and Saudi Arabia and quickly spread to some European countries since September 2012. Until 15 May 2014, it has infected at least 572 people with a fatality rate of about 30% globally. Studies to understand the virus and to develop antiviral drugs or therapy are necessary and urgent. In the present study, MERS-CoV papain-like protease (PLpro) is expressed, and its structural and functional consequences are elucidated.

Results: Circular dichroism and Tyr/Trp fluorescence analyses indicated that the secondary and tertiary structure of MERS-CoV PLpro is well organized and folded. Analytical ultracentrifugation analyses demonstrated that MERS-CoV PLpro is a monomer in solution. The steady-state kinetic and deubiquitination activity assays indicated that MERS-CoV PLpro exhibits potent deubiquitination activity but lower proteolytic activity, compared with SARS-CoV PLpro. A natural mutation, Leu105, is the major reason for this difference.

Conclusions: Overall, MERS-CoV PLpro bound by an endogenous metal ion shows a folded structure and potent proteolytic and deubiquitination activity. These findings provide important insights into the structural and functional properties of coronaviral PLpro family, which is applicable to develop strategies inhibiting PLpro against highly pathogenic coronaviruses.

Citing Articles

Interaction between coronaviruses and the autophagic response.

Yu J, Ge S, Li J, Zhang Y, Xu J, Wang Y Front Cell Infect Microbiol. 2024; 14:1457617.

PMID: 39650836 PMC: 11621220. DOI: 10.3389/fcimb.2024.1457617.

Yeast-Based Screening of Anti-Viral Molecules.

Srivastava V, Kumar R, Ahmad A Microorganisms. 2024; 12(3).

PMID: 38543629 PMC: 10974075. DOI: 10.3390/microorganisms12030578.

Utilizing sinapic acid as an inhibitory antiviral agent against MERS-CoV PLpro.

Shahid M, Alaofi A, Ansari M, Fayaz Ahmad S, Alsuwayeh S, Taha E Saudi Pharm J. 2024; 32(4):101986.

PMID: 38487020 PMC: 10937238. DOI: 10.1016/j.jsps.2024.101986.

Research Advances on Swine Acute Diarrhea Syndrome Coronavirus.

Liu C, Huang W, He X, Feng Z, Chen Q Animals (Basel). 2024; 14(3).

PMID: 38338091 PMC: 10854734. DOI: 10.3390/ani14030448.

Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies.

Ali Dahhas M, Alkahtani H, Malik A, Almehizia A, Bakheit A, Akber Ansar S Saudi Pharm J. 2022; 31(2):228-244.

PMID: 36540698 PMC: 9756750. DOI: 10.1016/j.jsps.2022.12.007.

References

Chan J, Li K, To K, Cheng V, Chen H, Yuen K . Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. J Infect. 2012; 65(6):477-89. PMC: 7112628. DOI: 10.1016/j.jinf.2012.10.002. View

Renatus M, Parrado S, DArcy A, Eidhoff U, Gerhartz B, Hassiepen U . Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure. 2006; 14(8):1293-302. PMC: 7126176. DOI: 10.1016/j.str.2006.06.012. View

Schuck P . Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000; 78(3):1606-19. PMC: 1300758. DOI: 10.1016/S0006-3495(00)76713-0. View

Chou C, Lai H, Chen H, Cheng S, Cheng K, Chou Y . Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease. Acta Crystallogr D Biol Crystallogr. 2014; 70(Pt 2):572-81. PMC: 7161584. DOI: 10.1107/S1399004713031040. View

Ratia K, Saikatendu K, Santarsiero B, Barretto N, Baker S, Stevens R . Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A. 2006; 103(15):5717-22. PMC: 1458639. DOI: 10.1073/pnas.0510851103. View

Wu C, Cheng S, Chen S, Li J, Fang Y, Chen Y . Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease. Acta Crystallogr D Biol Crystallogr. 2013; 69(Pt 5):747-55. PMC: 7161611. DOI: 10.1107/S0907444913001315. View

Eckerle I, Muller M, Kallies S, Gotthardt D, Drosten C . In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol J. 2013; 10:359. PMC: 3878046. DOI: 10.1186/1743-422X-10-359. View

Anderson L, Baric R . Emerging human coronaviruses--disease potential and preparedness. N Engl J Med. 2012; 367(19):1850-2. DOI: 10.1056/NEJMe1212300. View

Reusken C, Haagmans B, Muller M, Gutierrez C, Godeke G, Meyer B . Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013; 13(10):859-66. PMC: 7106530. DOI: 10.1016/S1473-3099(13)70164-6. View

10.

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

11.

Mielech A, Kilianski A, Baez-Santos Y, Mesecar A, Baker S . MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology. 2014; 450-451:64-70. PMC: 3957432. DOI: 10.1016/j.virol.2013.11.040. View

12.

Hsieh Y, Chou C . Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments. J Biomed Sci. 2011; 18:4. PMC: 3022805. DOI: 10.1186/1423-0127-18-4. View

13.

Hu M, Li P, Song L, Jeffrey P, Chenova T, Wilkinson K . Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 2005; 24(21):3747-56. PMC: 1276716. DOI: 10.1038/sj.emboj.7600832. View

14.

Brown P, Schuck P . Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J. 2006; 90(12):4651-61. PMC: 1471869. DOI: 10.1529/biophysj.106.081372. View

15.

Clementz M, Chen Z, Banach B, Wang Y, Sun L, Ratia K . Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol. 2010; 84(9):4619-29. PMC: 2863753. DOI: 10.1128/JVI.02406-09. View

16.

Chang H, Chou C, Chang G . Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride. Biophys J. 2006; 92(4):1374-83. PMC: 1783898. DOI: 10.1529/biophysj.106.091736. View

17.

Chen Z, Wang Y, Ratia K, Mesecar A, Wilkinson K, Baker S . Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. J Virol. 2007; 81(11):6007-18. PMC: 1900296. DOI: 10.1128/JVI.02747-06. View

18.

Zheng D, Chen G, Guo B, Cheng G, Tang H . PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 2008; 18(11):1105-13. PMC: 7091798. DOI: 10.1038/cr.2008.294. View

19.

Chou C, Chien C, Han Y, Trstenjak Prebanda M, Hsieh H, Turk B . Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biochem Pharmacol. 2008; 75(8):1601-9. PMC: 7092826. DOI: 10.1016/j.bcp.2008.01.005. View

20.

Wojdyla J, Manolaridis I, van Kasteren P, Kikkert M, Snijder E, Gorbalenya A . Papain-like protease 1 from transmissible gastroenteritis virus: crystal structure and enzymatic activity toward viral and cellular substrates. J Virol. 2010; 84(19):10063-73. PMC: 2937765. DOI: 10.1128/JVI.00898-10. View